Squarepoint
LABD icon

Squarepoint’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Squarepoint’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,490
Closed -$616K – 5042
2024
Q4 		$616K Buy
+8,490
New +$519K ﹤0.01% 3544

Other funds holding LABD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

Squarepoint's LABD Position: Q2 2026 in Review

Squarepoint increased its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 69% in Q2 2026, buying an estimated $609K and bringing the position to 110,977 shares worth $856K. The position accounts for ﹤0.01% of the portfolio, ranked #3023.

Squarepoint first reported a position in LABD in Q3 2021 and has held it in 7 quarters since. The position peaked at $1.65M in Q2 2022. 21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

  • Squarepoint held 110,977 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $856K as of Q2 2026.
  • Squarepoint bought 45,264 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2026, an estimated $609K.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3023 holding.
  • Squarepoint first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2021 and has held it in 7 quarters since.
  • Squarepoint's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $1.65M in Q2 2022.
  • 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.